期刊文献+

吴茱萸碱类化合物对阿尔茨海默病及脑血管疾病的药理作用研究进展 被引量:6

Research Progress on the Pharmacological Effects of Evodiamine Compounds on Alzheimer’s Disease and Cerebrovascular Disease
下载PDF
导出
摘要 吴茱萸碱和去氢吴茱萸碱是中药吴茱萸的主要活性成分,临床研究发现,这两种吴茱萸碱类化合物可通过多条途径减缓阿尔茨海默病的发展进程,此外,吴茱萸碱对脑血管疾病也具有显著疗效.本文综述近年来吴茱萸碱类化合物对阿尔茨海默病和脑血管疾病的药理作用,为临床应用吴茱萸碱和去氢吴茱萸碱治疗阿尔茨海默病和脑血管疾病提供参考. Evodiamine and dehydroevodiamine are the essential components of chinese traditional medicine Euodia rutaecarpa.Studies have found that these two compounds can slow down the development of Alzheimer’s disease in multiple ways,in addition to the effect of evodiamine on cerebrovascular diseases.This article reviews the pharmacological effects of evodiamine compounds on Alzheimer’s disease and cerebrovascular disease in recent years,providing reference for clinical application of evodiamine and dehydroevodiamine in the treatment of Alzheimer’s disease and cerebrovascular disease.
作者 抗晶晶 崔宁 Kang Jingjing;Cui Ning(School of Medicine,Huanghe College of Science and Technology,Zhengzhou 450063,China)
出处 《南京师大学报(自然科学版)》 CAS CSCD 北大核心 2021年第3期137-141,共5页 Journal of Nanjing Normal University(Natural Science Edition)
基金 河南省科技厅科技攻关项目(172102310208)。
关键词 吴茱萸碱 去氢吴茱萸碱 阿尔茨海默病 脑血管疾病 evodiamine dehydroevodiamine Alzheimer’s disease cerebrovascular disease
  • 相关文献

参考文献6

二级参考文献64

  • 1代蓉,殷义涛,高秀云.老年性痴呆中β淀粉样肽的研究进展[J].中国临床康复,2004,8(19):3858-3859. 被引量:10
  • 2黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1319
  • 3吕俊华,郭晶,杨文豪.绿茶多酚对D-半乳糖与Aβ25~35诱导的AD模型小鼠学习记忆障碍的改善作用[J].中药材,2006,29(4):352-354. 被引量:15
  • 4Ahn SH, Jeon SH, Tsuruo T, Shim CK, Chung SJ. Pharmacokinetic characterization of dehydroevodiamine in the rat brain. J Pharm Sci 2004: 93: 283-92.
  • 5Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986; 261 : 6084-9.
  • 6Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986; 83: 4913-7.
  • 7Lee VM, Balin B J, Otvos L Jr, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991; 251: 675-8.
  • 8Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245-9.
  • 9Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2:1403.
  • 10Giacobini E. From molecular structure to Alzheimer therapy. Jpn J Pharmacol 1997, 74: 225-41.

共引文献41

同被引文献83

引证文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部